Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 304
Selected: 0
NCT IDTitle
NCT03870152Electrocautery Ablation for the Prevention of Lung Cancer
NCT04870580[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy
NCT03994783Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
NCT02874729Assay Development for Cancer Biomarkers
NCT03294434Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
NCT00974792Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
NCT00758173Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT02866370Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
NCT01266486Effect of Metformin on Breast Cancer Metabolism
NCT05408169Increasing Uptake of Bowel Screening
NCT02520128A Study of IMRT in Primary Bone and Soft Tissue Sarcoma
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT02077569AKT Inhibitor in Oestrogen Positive Breast Cancer
NCT04084145National Unified Renal Translation Research Enterprise - Chronic Kidney Disease
NCT05770102DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT04060589ReIMAGINE Prostate Cancer Risk
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)
NCT05615818Personalized Medicine for Advanced Biliary Cancer Patients
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT00555386Soy, Selenium and Breast Cancer Risk
NCT03028766WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer
NCT03150576Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT05877352Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
NCT03994653Cancer Loyalty Card Study
NCT00080912Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
NCT01173900Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT01147029GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
NCT02544308Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma
NCT01791985AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)
NCT01196741Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer
NCT05057013A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT01160926Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial
NCT02330926Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
NCT01590160Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma
NCT03720041Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
NCT05770037DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
NCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial
NCT01654146ICON8: Weekly Chemotherapy in Ovarian Cancer
NCT02768337Cambridge Brain Mets Trial 1
NCT02741856Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation
NCT03432429Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
NCT00641095Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
NCT01993979A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
NCT05722886DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
NCT00427713Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
NCT00749450Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer